GeoVax Labs Inc. (GOVX) Downgraded by ValuEngine

GeoVax Labs Inc. (OTCMKTS:GOVX) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued on Saturday.

GeoVax Labs (OTCMKTS GOVX) opened at $0.07 on Friday. GeoVax Labs has a 12 month low of $0.02 and a 12 month high of $0.10.

GeoVax Labs (OTCMKTS:GOVX) last posted its quarterly earnings data on Thursday, November 9th. The biotechnology company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $0.25 million during the quarter, compared to analysts’ expectations of $0.30 million. sell-side analysts forecast that GeoVax Labs will post -0.04 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “GeoVax Labs Inc. (GOVX) Downgraded by ValuEngine” was published by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/11/25/geovax-labs-inc-govx-downgraded-by-valuengine.html.

GeoVax Labs Company Profile

GeoVax Labs, Inc (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company’s platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for GeoVax Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply